Binding of Akkermansia muciniphila to mucin is O-glycan specific

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 906 KB, PDF-dokument

The intestinal anaerobic bacterium Akkermansia muciniphila is specialized in the degradation of mucins, which are heavily O-glycosylated proteins that constitute the major components of the mucus lining the intestine. Despite that adhesion to mucins is considered critical for the persistence of A. muciniphila in the human intestinal tract, our knowledge of how this intestinal symbiont recognizes and binds to mucins is still limited. Here, we first show that the mucin-binding properties of A. muciniphila are independent of environmental oxygen concentrations and not abolished by pasteurization. We then dissected the mucin-binding properties of pasteurized A. muciniphila by use of a recently developed cell-based mucin array that enables display of the tandem repeats of human mucins with distinct O-glycan patterns and structures. We found that A. muciniphila recognizes the unsialylated LacNAc (Galβ1-4GlcNAcβ1-R) disaccharide selectively on core2 and core3 O-glycans. This disaccharide epitope is abundantly found on human colonic mucins capped by sialic acids, and we demonstrated that endogenous A. muciniphila neuraminidase activity can uncover the epitope and promote binding. In summary, our study provides insights into the mucin-binding properties important for colonization of a key mucin-foraging bacterium.
OriginalsprogEngelsk
Artikelnummer4582
TidsskriftNature Communications
Vol/bind15
Udgave nummer1
Antal sider10
ISSN2041-1723
DOI
StatusUdgivet - 2024

Bibliografisk note

Funding Information:
This work was supported by a Building Blocks of Life grant from the Dutch Research Council (NWO) (grant no. 737.016.003, J.E.), a FEMS Research and Training Grant (FEMS-GO-2021-069, J.E.), the Spinoza Award and SIAM Gravity Grant 024.002.002 of the Netherlands Organization for Scientific Research (NWO) of W.M.d.V. (J.E. and H.L.P.T.), the Danish National Research Foundation (DNRF107, H.C. and Y.N.), the Novo Nordisk Foundation (0071658, H.C. and Y.N.) and the Lundbeck Foundation (H.C. and Y.N.) and the European Research Council (ERC) under the European Union\u2019s Horizon 2020 research and innovation program (GlycoSkin H2020-ERC; 772735) (to N.H.).

Publisher Copyright:
© The Author(s) 2024.

ID: 394480278